Full name
BIOVIRTUS RESEARCH SITE SPÓŁKA Z OGRANICZONĄ ODPOWIEDZIALNOŚCIĄ W LIKWIDACJI
uses securityreCAPTCHA
72.11.Z - Research and experimental development on biotechnology
21.10.Z - Manufacture of basic pharmaceutical substances
21.20.Z - Manufacture of medicines and other pharmaceutical products
58.11.Z - Book publishing
70.2 - Management consultancy activities
72.1 - Research and experimental development on natural sciences and engineering
72.19.Z - Other research and experimental development on natural sciences and engineering
73.20.Z - Market research and public opinion polling
74.3 - Translation and interpretation activities
75.00.Z - Veterinary activities
2021 | 2022 | 2023 | ||
---|---|---|---|---|
M PLN | M PLN | M PLN | % | |
Profit (loss) on sale | -0,4 | -0,7 | -0,3 | 57,1 |
Gross profit (loss) | -0,4 | -1,4 | -0,7 | 51,2 |
EBITDA | -0,3 | -1,3 | -0,6 | 51,4 |
Short time liabilities | 0,9 | 0,6 | 1 | 84,6 |
Other operating costs | 0 | 1,2 | 0,4 | -65,6 |
Equity capital | 2 | 0,6 | -0,2 | -140,2 |
Operating profit (EBIT) | -0,4 | -1,4 | -0,7 | 50,9 |
Assets | 3,5 | 2,3 | 2,3 | -0,2 |
Net profit (loss) | -0,4 | -1,4 | -0,7 | 51,2 |
Cash | 1 | 0 | 0 | -29,4 |
Net income from sale | 2,1 | 1,8 | 2,7 | 47,5 |
Liabilities and provisions for liabilities | 1,5 | 1,7 | 2,5 | 49,7 |
Working assets | 2,3 | 1,2 | 1,2 | 3,8 |
Other income costs | 0 | 0,5 | 0 | -96,7 |
Depreciation | 0,1 | 0,1 | 0 | -39,4 |
% | % | % | p.p. | |
Profitability of capital | -19,7 | -226,5 | 274,6 | 501,1 |
Equity capital to total assets | 56,1 | 26,3 | -10,6 | -36,9 |
Gross profit margin | -18 | -74,3 | -24,6 | 49,7 |
EBITDA Margin | -15,6 | -71,2 | -23,5 | 47,7 |
Days | Days | Days | Days | |
Short term commitment turnover cycle | 159 | 114 | 142 | 28 |
Current financial liquidity indicator | 2.4932985305786133 | 2.094519853591919 | 1.1782389879226685 | -0,9 |
Opinie dotyczące usług, produktów oraz działalności firmy nie są weryfikowane